Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression

Abstract

Patients with MS present diffuse dysregulation in the monoaminergic networks. Specific alterations in these networks were associated with fatigue and depression, providing a pathological marker for these bothersome symptoms and putative targets for their treatment.